Source: Annual Congress 2005 - Exercise in respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Walker, N. Duffy, P. M. A. Calverley (Liverpool, United Kingdom). Emphysema phenotype predicts pattern of exercise response to bronchodilators in COPD. Eur Respir J 2005; 26: Suppl. 49, 767

Member's Comments

No comment yet.

Related content which might interest you: Lung function and exercise capacity in COPD phenotypes with and without emphysema Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Improvement in airflow obstruction with inhaled bronchodilators influences the pattern of abdominal muscle recruitment during exercise in COPD Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010 Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 The inflammatory response to high doses of terbutaline during an acute exercise bout in patients with severe COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Response to bronchodilation with tiotropium plus salbutamol correlates with radiologic morphology of the lung in COPD of the emphysematous phenotype Source: Annual Congress 2010 - Lung imaging Year: 2010 Acute and chronic effects of inhaled bronchodilators in patients with 'irreversible' COPD at rest and during exercise Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Emphysema and the physiological response to incremental exercise in COPD Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Airway resistance correlates with the frequency of exacerbation in patient with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Source: Eur Respir J 2016; 47: 651-654 Year: 2016 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016